Chauvergne J, Chomy P
Service de Médecine, Fondation Bergonié, Bordeaux.
Rev Mal Respir. 1989;6(5):409-16.
Chemotherapy of epidermoid bronchial cancer maintains, despite numerous therapeutic trails, a minimal efficacy and is shown to have no important effect on the duration of survival. Conversely, the immediate results obtained by chemotherapy for small cell carcinoma are remarkable particularly for the localised forms; there are numerous active drugs which can be usefully combined with radiotherapy to increase the level of complete remission and to attempt to influence the eventual outcome which remains unfavourable. However, this chemotherapy should benefit from the multiple research programmes which are currently underway to reinforce the effects of chemotherapy (new combinations of effective cytotoxic drugs, and the potential for changing biological responses) and to improve the techniques of application (for example, continuous infusions and chronomodulation). The intensification of chemotherapy (with or without the use of marrow transplants) seems to constitute, by the reduction of tumour mass that is induced, a factor determining the improvement in long-term results but is still limited only to small cell carcinomas.
尽管进行了大量治疗试验,但表皮样支气管癌的化疗疗效甚微,且对生存期并无显著影响。相反,小细胞癌化疗的近期效果显著,尤其是局限性小细胞癌;有多种活性药物可有效与放疗联合使用,以提高完全缓解率,并尝试影响最终仍不理想的治疗结果。然而,这种化疗应受益于当前正在进行的多项研究项目,这些项目旨在增强化疗效果(有效的细胞毒性药物新组合以及改变生物学反应的潜力)并改进应用技术(例如持续输注和时间调节)。强化化疗(无论是否使用骨髓移植)似乎通过诱导肿瘤体积缩小,成为决定长期治疗效果改善的一个因素,但目前仍仅限于小细胞癌。